scholarly article | Q13442814 |
review article | Q7318358 |
P356 | DOI | 10.1038/NM0997-944 |
P698 | PubMed publication ID | 9288711 |
P50 | author | Miguel P. Soares | Q41502664 |
P2093 | author name string | Wrighton CJ | |
Robson SC | |||
Bach FH | |||
Hancock WW | |||
Winkler H | |||
Ferran C | |||
Anrather J | |||
P2860 | cites work | A20 blocks endothelial cell activation through a NF-kappaB-dependent mechanism | Q28282198 |
Enzymatic remodelling of the carbohydrate surface of a xenogenic cell substantially reduces human antibody binding and complement-mediated cytolysis. | Q38288887 | ||
Human natural killer lymphocytes directly recognize evolutionarily conserved oligosaccharide ligands expressed by xenogeneic tissues | Q38345960 | ||
Cellular regulation of the protein C pathway | Q40946224 | ||
Molecular barriers to xenotransplantation | Q41089509 | ||
Human monocytes activate porcine endothelial cells, resulting in increased E-selectin, interleukin-8, monocyte chemotactic protein-1, and plasminogen activator inhibitor-type-1 expression | Q41127563 | ||
Adenovirus-mediated gene transfer of A20 renders endothelial cells resistant to activation: a means of evaluating the role of endothelial cell activation in xenograft rejection | Q41129290 | ||
Direct activation of porcine endothelial cells by human natural killer cells | Q41216527 | ||
Protective genes expressed in endothelial cells: a regulatory response to injury | Q41632984 | ||
T cell independence of macrophage and natural killer cell infiltration, cytokine production, and endothelial activation during delayed xenograft rejection | Q42528715 | ||
Targeting gene expression to endothelial cells in transgenic mice using the human intercellular adhesion molecule 2 promoter | Q45877880 | ||
Effects of leflunomide and deoxyspergualin in the guinea pig-->rat cardiac model of delayed xenograft rejection: suppression of B cell and C-C chemokine responses but not induction of macrophage lectin | Q46931472 | ||
Thrombin inhibition in an ex vivo model of porcine heart xenograft hyperacute rejection | Q71062264 | ||
Delayed xenograft rejection | Q71475338 | ||
Accommodation of vascularized xenografts: expression of "protective genes" by donor endothelial cells in a host Th2 cytokine environment | Q73034296 | ||
Effect of porcine endothelial tissue factor pathway inhibitor on human coagulation factors | Q73167450 | ||
Effect of continuous complement inhibition using soluble complement receptor type 1 on survival of pig-to-primate cardiac xenografts | Q73194300 | ||
P433 | issue | 9 | |
P407 | language of work or name | English | Q1860 |
P304 | page(s) | 944-948 | |
P577 | publication date | 1997-09-01 | |
P1433 | published in | Nature Medicine | Q1633234 |
P1476 | title | Modification of vascular responses in xenotransplantation: inflammation and apoptosis | |
P478 | volume | 3 |
Q33740179 | Accommodation |
Q42011946 | Amelioration of renal ischaemia-reperfusion injury by liposomal delivery of curcumin to renal tubular epithelial and antigen-presenting cells. |
Q61479732 | An in vivo model of hyperacute rejection: characterization and evaluation of the effect of transgenic human complement inhibitors |
Q77658697 | Antibody-induced transplant arteriosclerosis is prevented by graft expression of anti-oxidant and anti-apoptotic genes |
Q34786150 | Antibody-mediated activation of the classical complement pathway in xenograft rejection |
Q35595366 | Application of transgenesis in livestock for agriculture and biomedicine |
Q36368967 | Carbon monoxide generated by heme oxygenase 1 suppresses endothelial cell apoptosis. |
Q53574628 | Critical ethical issues in clinical trials with xenotransplants. |
Q33334538 | Disordered regulation of coagulation and platelet activation in xenotransplantation |
Q77632730 | Effect of FK 506 and splenectomy on orthotopic small bowel xenotransplantation in the hamster-to-rat animal models |
Q43687545 | Effect of treatment with prostaglandin E1 and N-acetylcysteine on pediatric liver transplant recipients: a single-center study |
Q42199653 | Effects of interfering RNA of α-1,3-galactosyltransferase and nuclear factor-kappa B on cardiac xenotransplantation |
Q56777593 | Ethical aspects in xenotransplantation |
Q46600986 | Extracorporeal circulation with an anticomplement synthetic polymer prolongs guinea pig-to-rat cardiac xenograft survival |
Q33692579 | Factors in xenograft rejection |
Q45856946 | Genetic cytoprotection of human endothelial cells during preservation time with an adenoviral vector encoding the anti-apoptotic human Bcl-2 gene |
Q34466735 | Graft vascular endothelium: its role in transplantation biology |
Q38823562 | Heme Oxygenases in Cardiovascular Health and Disease |
Q78081154 | IgY antiporcine endothelial cell antibodies effectively block human antiporcine xenoantibody binding |
Q36441318 | IkappaBalpha and IkappaBbeta possess injury context-specific functions that uniquely influence hepatic NF-kappaB induction and inflammation |
Q44266383 | Inhibition of TNF-alpha induced cell death in human umbilical vein endothelial cells and Jurkat cells by protocatechuic acid |
Q77355587 | Ischemia/reperfusion injury in the liver of BALB/c mice activates AP-1 and nuclear factor kappaB independently of IkappaB degradation |
Q47697484 | Lessons from an age-old war. |
Q44401629 | Metabonomic analysis of rats with acute heart rejection |
Q34530423 | NF-kappaB in transplantation: friend or foe? |
Q34471872 | Progress in reproductive biotechnology in swine |
Q34130341 | Rejection severity directly correlates with myocyte apoptosis in pig-to-baboon cardiac xenotransplantation |
Q39032896 | Spatiotemporal control of porcine p65RHD expression by advanced Tet-On system in PIEC cells helps regulate NFкB activity |
Q33781421 | The future of new immunosuppressive drugs |
Q45884088 | The pathology of cardiac xenografts |
Q34657049 | The role of heme oxygenase signaling in various disorders |
Q73787930 | The target antigens of naturally occurring human anti-beta-galactose IgG are cryptic on porcine aortic endothelial cells |
Q30838629 | Xenotransplantation |
Q73354889 | Xenotransplantation |
Q77070950 | Xenotransplantation |
Q34556780 | Xenotransplantation and ABO incompatible transplantation: the similarities they share |
Q74259343 | Xenotransplantation moratorium |
Q40826214 | Xenotransplantation: perspectives from The Netherlands |
Q73724833 | [Genetically engineered animals as organ donors in xenotransplantation] |
Search more.